A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance.
about
Molecular Mechanism of a Thumb Domain Hepatitis C Virus Nonnucleoside RNA-Dependent RNA Polymerase InhibitorRecent progress in herpes simplex virus immunobiology and vaccine researchOptimal antiviral switching to minimize resistance risk in HIV therapy.Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment.Modelling HIV-1 2-LTR dynamics following raltegravir intensification.Dynamics of HIV-1 recombination in its natural target cells.Controlling the Evolution of ResistanceVirologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropismEfficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.Mathematical Models of HIV Latency.Insight into treatment of HIV infection from viral dynamics models
P2860
Q27477757-6FA836CB-E0D8-4803-94ED-C419134FB2ACQ33963713-C66FC212-1E9D-4BC1-95D1-F544C699D0BCQ34071754-26CE32B4-8265-4298-A200-1D5633CE15C4Q34299035-C727A018-A95D-4302-8E8B-6C5743784147Q34737411-F96F8245-2282-4EFE-A311-835D45B029B7Q36904249-908A5670-1BBD-45AB-98D1-C355F6890FFDQ37356815-5FF9340B-0D5A-42A0-B508-301026F880EDQ37868426-1AC0600A-4471-4CAF-9014-4F0EC6A5DE11Q38969711-58B0F4F1-D0E0-43CD-942F-FF3327779B0DQ42245098-4CD0CA64-DB6F-4FE6-9F7A-DB0866C6AAA1Q47574091-5CC6326F-3DCA-46B1-8475-5381769070C3Q58788145-7CB83EAE-95C5-4B02-9BC8-14B0A6538E23
P2860
A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@ast
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@en
type
label
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@ast
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@en
prefLabel
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@ast
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@en
P1433
P1476
A combinatorial ledge: reverse ...... ution of antiviral resistance.
@en
P2093
P356
10.1016/S0166-3542(98)00062-X
P577
1999-02-01T00:00:00Z